Table 1. Characteristics of 290 patients undergoing CABG.
|
without complication | with complication | p-Value | |
---|---|---|---|---|
|
(n=254) | (n=36) | ||
Female (%) |
43 (16.9%) | 9 (25.0%) | .248 | |
Age (years) |
65.7 ± 9.7 | 66.5 ± 11.1 | .400 | |
Size (cm) |
170.6 ± 9.4 | 170.2 ± 9.5 | .603 | |
Weight (kg) |
81.5 ± 14.7 | 78.5 ± 17.7 | .275 | |
BSA (m2) | 1.9 ± 0.1 | 1.8 ± 0.2 | .390 | |
BMI (kg/m2) | 28 ± 4.7 | 26.9 ± 5 | .188 | |
Diabetes (%) | 69 (27.2%) | 11 (30.6%) | .692 | |
Dyslipidemia (%) | 207 (82.8%) | 30 (83.3%) | 1.000 | |
Hypertension (%) | 194 (76.4%) | 31 (86.1%) | .284 | |
Smoking (%) | 150 (59.3%) | 23 (65.7%) | .581 | |
CV hereditary (%) | 87 (37.2%) | 12 (37.5%) | 1.000 | |
Serum creatinin (umol/L) | 83.2 ± 23.5 | 107.6 ± 50.8 | .006 | |
Renal insufficiency (%) | 6 (2.4%) | 8 (22.2%) | <0.001 | |
COPD (%) | 25 (10.0%) | 8 (23.5%) | .039 | |
CCS class (%) | 0 | 50 (19.7%) | 4 (11.1%) | |
1 | 13 (5.1%) | 1 (2.8%) | ||
2 | 109 (42.9%) | 15 (41.7%) | .362 | |
3 | 57 (22.4%) | 9 (25.0%) | ||
4 | 25 (9.8%) | 7 (19.4%) | ||
NYHA class (%) | 1 | 106 (41.7%) | 9 (25.0%) | <0.001 |
2 | 105 (41.3%) | 12 (33.3%) | ||
3 | 41 (16.1%) | 12 (33.3%) | ||
4 | 2 (.8%) | 3 (8.3%) | ||
EuroSCORE additive | 3.1 ± 2.3 | 5.2 ± 3 | <0.001 | |
EuroSCORE logistic | 3 ± 2.6 | 6.7 ± 10.2 | 0.000 | |
LVEF (%) | 57.4 ± 12.2 | 50.1 ± 14.9 | 0.006 | |
Urgency / Emergency (%) | 42 (16.6%) | 11 (30.6%) | 0.063 | |
Previous stroke (%) | 10 (4.0%) | 3 (8.6%) | 0.205 | |
Previous PCI (%) | 0 | 202 (81.8%) | 24 (68.6%) | 0.155 |
1 | 44 (17.8%) | 11 (31.4%) | ||
2 | 1 (.4%) | 0 (.0%) | ||
Redo (%) | 2 (.8%) | 2 (5.6%) | 0.770 | |
PAOD (%) | 10 (3.9%) | 0 (.0%) | 0.479 | |
Carotid stenosis / previous carotid surgery (%) | 22 (10.4%) | 4 (12.9%) | 0.754 |
CABG, coronary artery bypass grafting; BSA, body surface area, BMI, body mass index; COPD, chronic obstructive pulmonary disease; CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PAOD, peripheral arterial obstructive disease